Utilizing the Superior Antibody-Dependent Cellular Cytotoxicity, Effector Functions, & Improved Persistence of g-NK Cells When Compared to Conventional NK cells
Time: 10:00 am
day: Innate Immune Checkpoints & Activation Pre-Focus Day
Details:
- Discussing the enhanced in vivo efficacy and persistence of g-NK cells and the ability of g-NK cells to induce regression of established tumors leading to durable elimination of tumor burden
- Elucidating the unique feature of g-NK cells which enable the development of an off-the-shelf cancer immunotherapy combined with therapeutic IgG antibodies
- Combining g-NK cells with anti-CD38 antibodies for the treatment of multiple myeloma without the need for genetic engineering
